Atomoxetine restores the response inhibition network in Parkinson’s disease
Impairments in response inhibition in Parkinson’s disease may reflect loss of noradrenaline and impaired fronto-subcortical connectivity. Rae et al. show that the noradrenaline reuptake inhibitor atomoxetine can restore functional connectivity in the inhibition network. Individual treatment response...
Full description
Bibliographic Details
| Main Authors: |
Rae, Charlotte L.,
Nombela, Cristina,
Rodríguez, Patricia Vázquez,
Ye, Zheng,
Hughes, Laura E.,
Jones, P. Simon,
Ham, Timothy,
Rittman, Timothy,
Coyle-Gilchrist, Ian,
Regenthal, Ralf,
Sahakian, Barbara J.,
Barker, Roger A.,
Robbins, Trevor W.,
Rowe, James B. |
|---|
| Format: | Online
|
|---|
| Language: | English |
|---|
| Published: |
Oxford University Press
2016
|
|---|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958901/
|
|---|